Urol. praxi. 2017;18(4):154-157 | DOI: 10.36290/uro.2017.036

Therapy resistant enuresis

MUDr. Pavel Drlík1, 2, MUDr. Marcel Drlík, FEAPU2, doc. MUDr. Jiří Heráček, Ph.D., MBA1, 2, MUDr. Jiří Kočárek, Ph.D.1, 2
1 Urologické oddělení ÚVN, VoFN Praha
2 Urologická klinika VFN a 1. LF UK Praha

Monosymptomatic nocturnal enuresis (MNE) is a common disease in childhood. Enuresis has a significant impact on the childand its family quality of life. In some cases treatment fails. The most common causes of a failure are: low patient's adherence totreatment, misdiagnosis of other underlying pathology and incorrect use of therapy. Repeated child and its parents' education,detailed reexamination aiming to rule out all possible missed pathologic conditions and detailed history of previous therapy arethe key points of success. The treatment should follow the International Children's Continence Society recommendations. The firstline treatment is represented by enuretic alarm and/or desmopressin, the second line includes administration of anticholinergics,imipramin should only be used as a third line treatment.

Keywords: mono-symptomatic nocturnal enuresis, adherence to treatment, desmopressin, enuretic alarm, anticholinergics, imipramin

Published: November 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Drlík P, Drlík M, Heráček J, Kočárek J. Therapy resistant enuresis. Urol. praxi. 2017;18(4):154-157. doi: 10.36290/uro.2017.036.
Download citation

References

  1. Lackgren G, et al. Nocturnal enuresis: a suggestion for European strategy. Acta Paediatr, 1999; 88: 679. Go to original source... Go to PubMed...
  2. Neveus T, et al. The standardization of terminology of Loir urinary tract fiction in children and adolescents: report from the Standardisation Committee of the International Children's kontinence society. J Urol, 2006; 176: 314. Go to original source... Go to PubMed...
  3. Neveus T, et al. Enuresis-background and treatment. Scand J Urol Nephrol Suppl, 2000. Go to original source...
  4. Crimmins EM. Childhood conditions and late-life health: introduction. Soc. Biol. 2005 Fall-winter; 52(3-4): 89-93. Go to original source... Go to PubMed...
  5. Kawauchi A, et al. Development of bladder capacity, nocturnal urinary volume and urinary behavior in nonenuretic and enuretic children. Jap J Urol, 1993; 84: 1811-1820. Go to original source... Go to PubMed...
  6. Caldwell PH, et al. Simple behavioural interventions for nocturnal enuresis in children. Cochrane Database Syst Rev, 2013, Cd 003637. Go to original source...
  7. Dehoorne JL, et al. Desmopressin toxicity due to prolonged half-life in 18 patiens with nocturnal enuresis. J Urol, 2006; 176: 754. Go to original source... Go to PubMed...
  8. Glazener CM, et al. Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev, 2002, Cd002112. Go to original source...
  9. Vande Walle JG, Bogaert GA, Mattsson S, Schurmans T, Hoebeke P, Deboe V, Norgaard JP. Desmopressin Oral Lyophilisate PD/PK Study Group. A new fast-melting oral formulation of desmopressin: a pharmacodynamic study in children with primary nocturnal enuresis. BJU Int. 2006; 97: 603-609. Go to original source... Go to PubMed...
  10. Glazener CM, et al. Alarm interventions for nocturnal enuresis in children. Cochrane diabase Syst Rev, 2005, Cd002911. Go to original source...
  11. Watanabe H. Treatment system for nocturnal enuresis according to an original classification system. Eur Urol, 1994; 25: 43-50. Go to original source... Go to PubMed...
  12. Kosilov KV, Loparev SA, Ivanovskaya MA, Kosilova LV. Night diuresis stimulation increases efficiency of alarm intervention. Pediatr Urol. 2015; 11: 261. Go to original source... Go to PubMed...
  13. Hjalmas K, et al. Nocturnal enuresis: an international evidence based management strategy. J Urol, 2004; 171: 2545. Go to original source... Go to PubMed...
  14. Glazener CM, et al. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev, 2003; Cd002117. Go to original source...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.